Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector

Recombinant vesicular stomatitis virus (rVSV) is currently under evaluation as a human immunodeficiency virus (HIV)-1 vaccine vector. The most compelling reasons to develop rVSV as a vaccine vector include a very low seroprevalence in humans, the ability to infect and robustly express foreign antige...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarke, David K., Cooper, David, Egan, Michael A., Hendry, R. Michael, Parks, Christopher L., Udem, Stephen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2006
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079905/
https://www.ncbi.nlm.nih.gov/pubmed/16977404
http://dx.doi.org/10.1007/s00281-006-0042-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079905/
https://www.ncbi.nlm.nih.gov/pubmed/16977404
http://dx.doi.org/10.1007/s00281-006-0042-3

Ejemplares similares